![](/img/cover-not-exists.png)
Immunomodulatory effects of high-dose and low-dose interferon α2b in patients with high-risk resected melanoma : The E2690 laboratory corollary of Intergroup Adjuvant Trial E1690
John M. Kirkwood, Thomas Richards, Hassane M. Zarour, Jeffrey Sosman, Marc Ernstoff, Theresa L. Whiteside, Joseph Ibrahim, Ronald Blum, Samuel Wieand, Ruth MascariVolume:
95
Year:
2002
Language:
english
Pages:
12
DOI:
10.1002/cncr.10775
File:
PDF, 177 KB
english, 2002